FN1 and cancer: As key participants in TME, CAFs can promote ECM deposition by producing fibrotic compounds such as collagen, hyaluronic acid, and fibronectin (Tian et al., 2019), and also have complex crosstalk with cancer and immune cells (Kota et al., 2017).